HH IMV Holdings, L.P. - Net Worth and Insider Trading
HH IMV Holdings, L.P. Net Worth
The estimated net worth of HH IMV Holdings, L.P. is at least $26 Million dollars as of 2024-06-23. HH IMV Holdings, L.P. is the 2201 Interest of corporation controlled by you of Clover Biopharmaceuticals Ltd and owns about 70,797,172 shares of Clover Biopharmaceuticals Ltd (HKSE:02197) stock worth over $26 Million. Details can be seen in HH IMV Holdings, L.P.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that HH IMV Holdings, L.P. has not made any transactions after 2022-12-13 and currently still holds the listed stock(s).
Transaction Summary of HH IMV Holdings, L.P.
HH IMV Holdings, L.P. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, HH IMV Holdings, L.P. owns 1 companies in total, including Clover Biopharmaceuticals Ltd (HKSE:02197) .
Click here to see the complete history of HH IMV Holdings, L.P.’s form 4 insider trades.
Insider Ownership Summary of HH IMV Holdings, L.P.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:02197 | Clover Biopharmaceuticals Ltd | 2022-12-13 | 2201 Interest of corporation controlled by you |
HH IMV Holdings, L.P. Latest Holdings Summary
HH IMV Holdings, L.P. currently owns a total of 1 stock. HH IMV Holdings, L.P. owns 70,797,172 shares of Clover Biopharmaceuticals Ltd (HKSE:02197) as of December 13, 2022, with a value of $26 Million.
Latest Holdings of HH IMV Holdings, L.P.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:02197 | Clover Biopharmaceuticals Ltd | 2022-12-13 | 70,797,172 | 0.37 | 25,840,968 |
Holding Weightings of HH IMV Holdings, L.P.
HH IMV Holdings, L.P. Form 4 Trading Tracker
According to the SEC Form 4 filings, HH IMV Holdings, L.P. has made a total of 2 transactions in Clover Biopharmaceuticals Ltd (HKSE:02197) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Clover Biopharmaceuticals Ltd is the sale of 0 shares on December 13, 2022, which brought HH IMV Holdings, L.P. around $0.
Insider Trading History of HH IMV Holdings, L.P.
- 1
HH IMV Holdings, L.P. Trading Performance
HH IMV Holdings, L.P. Ownership Network
HH IMV Holdings, L.P. Owned Company Details
What does Clover Biopharmaceuticals Ltd do?
Who are the key executives at Clover Biopharmaceuticals Ltd?
HH IMV Holdings, L.P. is the 2201 Interest of corporation controlled by you of Clover Biopharmaceuticals Ltd. Other key executives at Clover Biopharmaceuticals Ltd include 2101 Beneficial owner Liang Peng , 2501 Other Liang Joshua G , and 2201 Interest of corporation controlled by you JPMorgan Chase & Co. .
Clover Biopharmaceuticals Ltd (HKSE:02197) Insider Trades Summary
Over the past 18 months, HH IMV Holdings, L.P. made no insider transaction in Clover Biopharmaceuticals Ltd (HKSE:02197). Other recent insider transactions involving Clover Biopharmaceuticals Ltd (HKSE:02197) include a net purchase of 1,519,000 shares made by Liang Joshua G , and a net sale of 6,500 shares made by Liang Peng .
In summary, during the past 3 months, insiders sold 500 shares of Clover Biopharmaceuticals Ltd (HKSE:02197) in total and bought 0 shares, with a net sale of 500 shares. During the past 18 months, 6,500 shares of Clover Biopharmaceuticals Ltd (HKSE:02197) were sold and 1,519,000 shares were bought by its insiders, resulting in a net purchase of 1,512,500 shares.
Clover Biopharmaceuticals Ltd (HKSE:02197)'s detailed insider trading history can be found in Insider Trading Tracker table.
Clover Biopharmaceuticals Ltd Insider Transactions
HH IMV Holdings, L.P. Mailing Address
Above is the net worth, insider trading, and ownership report for HH IMV Holdings, L.P.. Currently GuruFocus does not have mailing address information for HH IMV Holdings, L.P..
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
